A detailed history of Masso Torrence Wealth Management Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Masso Torrence Wealth Management Inc. holds 703 shares of LLY stock, worth $510,181. This represents 0.35% of its overall portfolio holdings.

Number of Shares
703
Previous 625 12.48%
Holding current value
$510,181
Previous $565,000 10.09%
% of portfolio
0.35%
Previous 0.33%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$772.14 - $960.02 $60,226 - $74,881
78 Added 12.48%
703 $622,000
Q2 2024

Jul 22, 2024

BUY
$724.87 - $909.04 $9,423 - $11,817
13 Added 2.12%
625 $565,000
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $362,426 - $484,875
612 New
612 $476,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $690B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Masso Torrence Wealth Management Inc. Portfolio

Follow Masso Torrence Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Masso Torrence Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Masso Torrence Wealth Management Inc. with notifications on news.